Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J8MA
|
|||
Drug Name |
KA2237
|
|||
Indication | B-cell lymphoma [ICD-11: 2A86; ICD-10: C85.1; ICD-9: 202.8] | Phase 1 | [1] | |
Company |
Karus Therapeutics Oxfordshire, United Kingdom
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.